Evaporation Residue Testing of Medical Plastics: Standards, Methods, and Regulatory Compliance

Evaporation residue testing is a core chemical characterization method for medical plastic devices and pharmaceutical packaging, quantifying the total non-volatile substances that migrate from polymeric materials into extraction media. This article explains the testing principle, applicable standards such as GB/T 14233.1 and ISO 10993, typical samples and acceptance limits, step-by-step procedures, and practical applications, helping manufacturers ensure material safety and regulatory compliance.

Technical Overview

Evaporation residue testing is a gravimetric chemical analysis used to determine the total quantity of non-volatile substances that can migrate out of a medical plastic material into a defined extraction medium under simulated clinical-use conditions. The measured residue represents the combined mass of dissolved oligomers, residual monomers, plasticizers, antioxidants, processing aids, lubricants, and degradation products released by the polymer during contact with drug solutions, blood, or body fluids.

Medical-grade polymers such as polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polyurethane (PU), polycarbonate (PC), polyethylene terephthalate (PET), and thermoplastic elastomers (TPE) rely on additives to achieve their performance. If these substances leach excessively into a patient-contact fluid, they may introduce toxicological risk or alter the quality of the administered drug. Evaporation residue therefore serves as a global screening indicator of overall extractable matter and constitutes a mandatory chemical requirement in the GB/T 14233 series for medical devices, in pharmaceutical packaging monographs, and as supporting evidence within ISO 10993 chemical characterization programs.

Typical contributors to the evaporation residue of medical plastics include:

• Residual monomers and low-molecular-weight oligomers from incomplete polymerization
• Plasticizers, such as phthalate esters or citrate-based alternatives
• Antioxidants, heat stabilizers, and UV absorbers
• Slip agents, lubricants, and mold-release residues from processing
• Colorants, fillers, and degradation or sterilization by-products

Testing Samples

Infusion, Transfusion, and Injection Devices

Disposable sterile syringes, infusion sets, blood transfusion sets, intravenous catheters, extension tubing, needles with plastic hubs, injection filters, and stopcocks are the primary sample categories. Extraction is generally performed on the complete device or on the components that are in direct contact with the administered fluid, in accordance with the applicable product standard.

Pharmaceutical and Medical Packaging

Flexible infusion bags, plastic bottles for oral or injectable preparations, blister films and lidding materials containing polymer layers, closures, caps, and gaskets are tested against pharmacopoeial and national packaging monographs. For these products, evaporation residue is commonly evaluated in multiple food- and drug-simulating media rather than water alone.

Other Medical Polymer Products

Dialyzer housings and blood pathways, oxygenators, drainage sets, feeding tubes, wound dressings, laboratory consumables, and polymer components of drug-device combination products are also routinely assessed for migratable residue.

Raw Materials and Compounds

Resin pellets, compounds, and masterbatches can be screened at the incoming-inspection stage, allowing manufacturers to qualify suppliers and detect additive excess before component production.

Testing Items

The core test item is the evaporation residue of the aqueous extract determined under the GB/T 14233.1 chemical analysis method for medical infusion, transfusion, and injection equipment. Depending on the product type and applicable standard, the scope may be extended as follows:

• Evaporation residue in a purified water extract, the baseline test for most device standards
• Evaporation residue in additional contact simulants required by packaging monographs, such as 4% acetic acid, ethanol-water mixtures (for example 65% ethanol), and n-hexane for lipophilic or oily contact
• Associated chemical tests typically executed in the same test program: reducing substances (potassium permanganate consumption), pH change, heavy metals, ultraviolet absorbance of the extract, turbidity, and color
• Supporting extractables and leachables (E&L) screening aligned with ISO 10993-18 chemical characterization

Acceptance limits are defined in the individual product or monograph standards and commonly fall in the range of 2 mg to 5 mg per extraction aliquot for device applications. For example, the national standard for disposable sterile infusion sets limits the evaporation residue to no more than 5 mg, whereas packaging monographs typically express limits as milligrams per liter of extract for each simulant.

Testing Methods

Applicable Standards and Frameworks

• GB/T 14233.1, which specifies the evaporation residue procedure and test solution preparation for medical infusion, transfusion, and injection equipment
• Product standards such as those governing disposable infusion sets, sterile syringes, and blood bags, which define limits and extraction geometry
• National pharmaceutical packaging standards (YBB monographs) requiring multi-simulant evaporation residue testing
• GB 31604.8 and the GB 4806 series for food-contact style migration testing where relevant
• ISO 10993-12 and ISO 10993-18 for sample preparation and chemical characterization context, together with USP General Chapters 661.1 and 661.2 and the European Pharmacopoeia section 3.1 for packaging polymers in international markets

Test Principle

A measured volume of the extract is transferred into a pre-conditioned, constant-mass evaporating dish, evaporated to dryness on a water bath, dried to constant weight at 105 °C, cooled in a desiccator, and weighed on an analytical balance. The difference between the final and initial dish masses, corrected by a blank determination performed on the extraction medium alone, is reported as the evaporation residue.

Sample Preparation and Extraction

The test solution is typically prepared by extracting the sample with purified water at 37 °C ± 1 °C for 24 h ± 2 h, reproducing physiological contact conditions. For irregularly shaped components, a surface-area-to-volume ratio of approximately 6 cm² per milliliter is commonly applied, while complete devices may be filled and extracted as a whole where the product standard permits. Reagent blanks are prepared identically to control for water and glassware contributions.

Determination Procedure

• Condition quartz, platinum, or borosilicate evaporating dishes to constant mass at 105 °C and record each mass to 0.1 mg on a calibrated analytical balance
• Pipette an accurately measured aliquot of the test solution, typically 50 mL, into the tared dish
• Evaporate gently on a boiling water bath, taking care to prevent splashing or loss of residue
• Dry the dish and residue at 105 °C until constant mass is achieved, generally indicated when consecutive weighings differ by no more than 0.3 mg
• Cool in a desiccator for about 30 minutes before each weighing and run a parallel blank determination

Calculation and Expression of Results

The evaporation residue equals the mass of the dish plus dried residue minus the original dish mass, further corrected by subtracting the blank residue. Results may be expressed as milligrams per extraction aliquot, per device, per liter of extract, or normalized to the contact surface area, depending on the format required by the governing standard.

Quality Control and Influencing Factors

• Use of high-purity water and scrupulously cleaned glassware to minimize blank bias and improve detection capability
• Strict control of extraction temperature and duration, because leaching behavior is temperature and time dependent
• Verification of balance calibration and stable weighing environments free from vibration, drafts, and humidity fluctuation
• Protection of samples from airborne particulate contamination during evaporation and cooling
• Consideration of the sterilization method, since ethylene oxide residuals or radiation-induced degradation products can measurably increase residue levels

Applications

Evaporation residue data support the entire lifecycle of a medical plastic product, from material selection to market surveillance:

• Product registration dossiers and market approval submissions for medical devices
• Routine batch release and in-process quality control during manufacturing
• Supplier qualification, incoming resin inspection, and comparability studies after material, formulation, or process changes
• Sterilization validation and shelf-life (stability) programs
• Toxicological risk assessment input, where the total residue supports safety evaluation in line with ISO 10993-17 and ISO 10993-18
• Export compliance, where importing authorities request chemical test reports issued by accredited third-party laboratories

Manufacturers commonly partner with accredited third-party laboratories equipped with 0.1 mg analytical balances, constant-temperature incubators, water baths, drying ovens, and controlled desiccation facilities to obtain traceable, reportable results for regulatory submission.

FAQ

What does evaporation residue indicate about a medical plastic?

It provides an overall measure of all non-volatile substances capable of migrating from the material into a contact fluid. A high result signals excessive additives, incompletely reacted monomers, processing residues, or polymer degradation, prompting further targeted chemical identification.

Which extraction conditions are standard?

For device testing under the GB/T 14233 series, purified water at 37 °C for 24 hours is the standard condition, using whole-device extraction or a defined surface-area-to-volume ratio. Packaging monographs may additionally require acidic, alcoholic, and hydrocarbon simulants to simulate different drug or food contact scenarios.

What are the typical acceptance limits?

Limits are set by individual product standards and commonly range from 2 mg to 5 mg per extraction aliquot, with disposable infusion sets limited to no more than 5 mg. Packaging applications typically specify limits in milligrams per liter for each simulant as defined in the applicable monograph.

How much sample is required and how long does testing take?

Sample requirements depend on device geometry and typically involve several complete devices or a specified contact surface area of material. Including extraction, evaporation, and constant-weight drying cycles, turnaround is commonly within seven to ten working days.

How does this test relate to extractables and leachables studies?

Evaporation residue is a rapid gravimetric screening method that quantifies total migratable non-volatile matter. It complements chromatographic and spectrometric E&L analysis performed under ISO 10993-18, where the total residue value helps define the scope and sensitivity of subsequent targeted identification work.